HOME >> MEDICINE >> NEWS
Cranberry juice may reduce risk of female urinary tract infections

The tangy flavor of cranberries could make life just a little sweeter for some. Drinking cranberry juice on a regular basis may help prevent urinary tract infections (UTIs) in some women, according to a review article in the May 15 issue of Clinical Infectious Diseases, now available online.

Cranberries contain two compounds that keep infection-causing bacteria from adhering to the lining of the urinary tract. Whether provided in juice or tablet form, the contents of the berries have been the subject of clinical study since 1966 in association with urinary tract infections and bacteriuria (the existence of bacteria in the urine). The review noted, however, that limitations in many of the studies conducted, such as small size, short duration, or use of a wide variety of cranberry products and dosing levels, make the results difficult to assess and compare.

The group most likely to reap benefits from regular doses of cranberry juice or tablets is sexually active adult women with recurring UTIs, who may experience a 50 percent drop in infection rates, according to some findings. Cranberry juice's value in treating already-established cases of UTI is unknown, as most studies have focused on its ability to prevent infection.

The appeal of cranberry juice as a potential preventative of UTI lies not just in its taste and familiarity, though, according to lead author Dr. Raul Raz of Haemek Medical Center in Afula, Israel. "It is a natural tendency to take 'natural products' instead of antibiotics, not only for UTI. I believe that if good clinical studies are conducted showing a beneficial effect of cranberries in UTI, physicians will also recommend using it," Dr. Raz said.

If more controlled studies of cranberries' effect on UTI do take place, Dr. Raz believes they should be varied. "In general, we need more clinical studies with different population groups, different dosages, and comparison between juice and capsules," he said.
'"/>

Contact: Jeff Minerd
jminerd@idsociety.org
703-299-0412
Infectious Diseases Society of America
28-Apr-2004


Page: 1 2

Related medicine news :

1. Cranberry component linked to reduced stroke damage
2. Grapefruit juice and medication can be a dangerous mix
3. Orange juice fortified with plant sterols found to lower bad cholesterol in healthy volunteers
4. Concord grape juice improved memory and neuro-motor skills in animal study
5. Study provides new evidence that cranberry juice may help fight heart disease
6. Colic in infants linked to inability to digest apple juice, but not white grape juice
7. Vitamin C may help juice up metabolism in older adults, offsetting weight gain
8. Glue ear could be caused by gastric juices
9. Charcoal and forest management could reduce greenhouse gas levels & save lives in Africa
10. Geodon effective in psychiatric emergencies; Sharply reduces time in restraints
11. Mouse model reveals potential way to reduce cardiac deaths in kidney patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cranberry juice may reduce risk female urinary tract infections

(Date:10/22/2014)... 2014 On Saturday, October 25, 2014, the ... family health and fitness fair ¡Vive tu vida! Get Up! ... good nutrition for better health and wellness for people of ... and open to the public, will be held at Dean ... am to 1:00 pm. , “¡Vive tu Vida! Get ...
(Date:10/22/2014)... 2014 Isabel Healthcare will ... Professions (ASAHP) Conference on October 22-24 in Las Vegas, ... in a panel discussion on Technology in Health Professions ... provides a diagnostic decision support tool and clinical education ... of students and clinical learners. The Isabel tools help ...
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... California (PRWEB) October 22, 2014 Hay House ... Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) written ... of Yoga & Recovery. This book is meant to ... in a life of recovery. , Recovery 2.0 is ... 12 Steps; Recovery 2.0 is a guide for what comes ...
(Date:10/22/2014)... 22, 2014 Best Cheap Hosting USA ... world. The site has recently announced that iPower ( ... for people from around the world. , “iPower is ... today and is providing various kinds of useful products ... insists on offering excellent customer service and a number ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, ... MKT: AMPE), today announced that its academic collaborators ... and research potential for its novel RedoxSYS Diagnostic ... (ORP) in the body in response to injury ... of ORP as a clinical marker will be ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
Cached News: